Product Information
RAMIPRIL 1.25 MG CAPSULE is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $0.0867 per EA under NDC 76282067001. Its NADAC has been published 315 times since Jun 17, 2020.
Strength
1.25 mg/1
Manufacturer
Exelan Pharmaceuticals Inc.NDC
76282067001
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RAMIPRILApproval Type
Generic (ANDA)
FDA Application
ANDA077900On Market Since
6/18/2008
Pharmacological Classes
Price Statistics
The NADAC for RAMIPRIL 1.25 MG CAPSULE has been published 315 times since Jun 17, 2020, and over the history we have for it it has declined 20.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0867 per EA |
|---|---|
| All-time high | $0.1631 (Dec 16, 2020) |
| All-time low | $0.0626 (Jul 17, 2024) |
| 52-week high | $0.0989 |
| 52-week low | $0.0778 |
| Median price | $0.0975 |
| Average price | $0.1016 |
| Largest weekly change | +82.1% (Mar 20, 2024) |
| Weeks tracked | 315 |
| Tracking since | Jun 17, 2020 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RAMIPRIL 1.25 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for RAMIPRIL 1.25 MG CAPSULE, manufactured by Exelan Pharmaceuticals Inc., is $0.0867 per EA (NDC 76282067001), effective Jun 24, 2026.
How has the price of RAMIPRIL 1.25 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for RAMIPRIL 1.25 MG CAPSULE has declined 20.0%. It has been tracked across 315 weekly CMS publications since Jun 17, 2020.
What are the highest and lowest recorded NADAC prices for RAMIPRIL 1.25 MG CAPSULE?
Since Jun 17, 2020, the NADAC for RAMIPRIL 1.25 MG CAPSULE has ranged from a low of $0.0626 (Jul 17, 2024) to a high of $0.1631 (Dec 16, 2020), with a median of $0.0975 per EA.
Are there cheaper alternatives to RAMIPRIL 1.25 MG CAPSULE?
6 NADAC-published products share the same active ingredient, strength, and dosage form as RAMIPRIL 1.25 MG CAPSULE, but none are currently priced below it.
Who manufactures RAMIPRIL 1.25 MG CAPSULE?
RAMIPRIL 1.25 MG CAPSULE (NDC 76282067001) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification